These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7509966)

  • 21. Glutamate receptor blockade attenuates glucose hypermetabolism in perihematomal brain after experimental intracerebral hemorrhage in rat.
    Ardizzone TD; Lu A; Wagner KR; Tang Y; Ran R; Sharp FR
    Stroke; 2004 Nov; 35(11):2587-91. PubMed ID: 15375303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of periaqueductal gray area NMDA receptors in endothelin-induced behavioural effects.
    Maione S; D'Amico M; Berrino L; Filippelli A; Leyva J; Rossi F
    Eur J Pharmacol; 1993 Nov; 250(1):209-12. PubMed ID: 7907022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of effect of L-687,414 ((+)-cis-4-methyl-HA-966), an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology.
    Hargreaves RJ; Rigby M; Smith D; Hill RG
    Br J Pharmacol; 1993 Sep; 110(1):36-42. PubMed ID: 8220897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Competitive (AP7) and non-competitive (MK-801) NMDA receptor antagonists differentially alter glucose utilization in rat cortex.
    Clow DW; Lee SJ; Hammer RP
    Synapse; 1991 Apr; 7(4):260-8. PubMed ID: 1828310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral and metabolic changes in immature rats during seizures induced by homocysteic acid: the protective effect of NMDA and non-NMDA receptor antagonists.
    Folbergrová J; Haugvicová R; Mares P
    Exp Neurol; 2000 Jan; 161(1):336-45. PubMed ID: 10683299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Icilin induces a hyperthermia in rats that is dependent on nitric oxide production and NMDA receptor activation.
    Ding Z; Gomez T; Werkheiser JL; Cowan A; Rawls SM
    Eur J Pharmacol; 2008 Jan; 578(2-3):201-8. PubMed ID: 17976579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opioid-induced epileptogenic phenomena: anatomical, behavioral, and electroencephalographic features.
    Chugani HT; Ackermann RF; Chugani DC; Engel J
    Ann Neurol; 1984 Apr; 15(4):361-8. PubMed ID: 6742781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of effects of inhibition of nitric oxide synthesis on local glucose utilization in the rat brain.
    Takahashi S; Cook M; Jehle J; Kennedy C; Sokoloff L
    J Neurochem; 1995 Jul; 65(1):414-9. PubMed ID: 7790888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of effects of the kappa-opioid agonist CI-977 on cerebral glucose utilization in rat brain.
    Mackay KB; McCulloch J
    Brain Res; 1994 Apr; 642(1-2):160-8. PubMed ID: 8032876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain sites involved in mu-opioid receptor-mediated actions: a 2-deoxyglucose study.
    Fabian I; Ableitner A
    Brain Res; 1995 Oct; 697(1-2):205-15. PubMed ID: 8593578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of chronic administration of MK-801 upon local cerebral glucose utilisation and ligand binding to the NMDA receptor complex.
    Kurumaji A; Ikeda M; Dewar D; McCormack AG; McCulloch J
    Brain Res; 1991 Nov; 563(1-2):57-65. PubMed ID: 1838495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of intracisternal endothelin-1 injection on blood flow to the lower brain stem.
    Macrae I; Robinson M; McAuley M; Reid J; McCulloch J
    Eur J Pharmacol; 1991 Oct; 203(1):85-91. PubMed ID: 1797558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrahippocampal injection of endothelin-1: a new model of ischemia-induced seizures in immature rats.
    Tsenov G; Mátéffyová A; Mares P; Otáhal J; Kubová H
    Epilepsia; 2007; 48 Suppl 5():7-13. PubMed ID: 17910575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of seizure-mediating brain structures with the deoxyglucose method: studies of human epilepsy with positron emission tomography, and animal seizure models with contact autoradiography.
    Ackermann RF; Engel J; Phelps ME
    Adv Neurol; 1986; 44():921-34. PubMed ID: 3518352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in regional brain metabolism in genetic and pharmacological models of reduced NMDA receptor function.
    Duncan G; Miyamoto S; Gu H; Lieberman J; Koller B; Snouwaert J
    Brain Res; 2002 Oct; 951(2):166-76. PubMed ID: 12270494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of nitric oxide synthesis: effects on cerebral blood flow and glucose utilisation in the rat.
    Macrae IM; Dawson DA; Norrie JD; McCulloch J
    J Cereb Blood Flow Metab; 1993 Nov; 13(6):985-92. PubMed ID: 7691855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of the non-NMDA receptor antagonist, 2,3-dihydro-6-nitro-7-sulfamoylbenzo(f)quinoxaline, on local cerebral glucose uptake in the limbic forebrain.
    Suzdak PD; Sheardown MJ
    J Neurochem; 1993 Oct; 61(4):1577-80. PubMed ID: 8397300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral blood flow and metabolism in soman-induced convulsions.
    Shih TM; Scremin OU
    Brain Res Bull; 1992 May; 28(5):735-42. PubMed ID: 1617457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of the calcium antagonist nimodipine upon local cerebral glucose utilization in the rat brain.
    d'Avella D; Cicciarello R; La Torre F; Princi P; Greenberg RP; d'Aquino S; Caputi AP
    Life Sci; 1984 Jun; 34(26):2583-8. PubMed ID: 6738297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia.
    Dawson DA; Graham DI; McCulloch J; Macrae IM
    Br J Pharmacol; 1994 Sep; 113(1):247-53. PubMed ID: 7529111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.